Personalized Immune Cell Treatment NKCL Classic

NKCL International to be listed on the London Stock Exchange.

NKCL 2020.02.13 19:25
CN 1.png   KR1.png

[NKCL] GK Global Group works in earnest on listing of NKCL International on the London Stock Exchange. 

GK Global Group, the parent company of NKCL, took a first step for NKCL International (NKCL Distribution and Sales Corporation) 
to be listed on the mainboard of the London Stock Exchange.
GK Global Group has made a takeover contract with FPP (Fragrant Prosperity Holdings Limited) in July 21st, 2019, 
which was listed on the London Stock Exchange, and finalized its takeover process on last Friday, November 8th, 2019. 


The takeover contract between GK Global Group and FPP

FPP’s listing status on the London Stock Exchange is available on the following London Stock Exchange website:


The listing status of FPP on the London Stock Exchange

In the future, GK Global Group will transform it into NKCL International anwill implement strategies to increase the corporate value of NKCL International. 

NKCL is a corporation that operates personalized immune care platforms which utilize NK cells, which are immune cells. Recently, it successfully held grand launching events in Malaysia and Hong Kong and introduced to the world. It is said to have created a new platform that combined the IT industry and the bio industry with high completion.It is also expected that the mainboard listing of NKCL International, which is responsible for the distribution and sales of all the products and platforms of NKCL, would have a great effect on the development of the global NKCL business. 


A photography of NKCL launching event in Hong Kong


A photography of NKCL launching event in Malaysia

Source : London Stock Exchange
Attach Files